Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | Nov 20, 2024 | 0.18 | -9.60 |
T-Mobile US | TMUS | Nov 20, 2024 | 235.47 | +0.97 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Nov 20, 2024 | 41.64 | -0.19 |
T. Rowe Price Dividend Growth ETF | TDVG | Nov 20, 2024 | 40.74 | +0.15 |
T. Rowe Price Equity Income ETF | TEQI | Nov 20, 2024 | 42.57 | +0.18 |
T. Rowe Price Group | TROW | Nov 20, 2024 | 117.52 | -0.36 |
T. Rowe Price Growth Stock ETF | TGRW | Nov 20, 2024 | 39.39 | 0.00 |
T2 Biosystems | TTOO | Nov 20, 2024 | 0.46 | -4.39 |
Taboola.com | TBLA | Nov 20, 2024 | 3.30 | +4.76 |
Tactile Systems Technology | TCMD | Nov 20, 2024 | 15.56 | -1.33 |
Taitron Components A | TAIT | Nov 20, 2024 | 2.61 | -1.33 |
Taiwan Fund | TWN | Nov 20, 2024 | 43.03 | -0.36 |
Taiwan Index MSCI Ishares | EWT | Nov 20, 2024 | 53.65 | -1.03 |
Taiwan Semiconductor Manufacturing ADR | TSM | Nov 20, 2024 | 188.36 | -0.69 |
Take-Two Interactive Software | TTWO | Nov 20, 2024 | 185.50 | -0.27 |
Takeda Pharmaceutical ADR | TAK | Nov 20, 2024 | 13.29 | -2.42 |
TAL Education Group ADR | TAL | Nov 20, 2024 | 10.13 | +2.22 |
Talen Energy | TLN | Nov 20, 2024 | 206.09 | -4.01 |
Talis Biomedical | TLIS | Nov 20, 2024 | 4.38 | 0.00 |
Talkspace | TALK | Nov 20, 2024 | 3.16 | +2.27 |
Talos Energy | TALO | Nov 20, 2024 | 11.45 | +3.81 |
Talphera | TLPH | Nov 20, 2024 | 0.71 | +5.42 |
Tamboran Resources | TBN | Nov 20, 2024 | 17.95 | -3.80 |
Tandem Diabetes Care | TNDM | Nov 20, 2024 | 30.15 | +8.18 |
Tanger | SKT | Nov 20, 2024 | 36.43 | -0.22 |
Tango Therapeutics | TNGX | Nov 20, 2024 | 4.08 | +5.97 |
Tantech | TANH | Nov 20, 2024 | 0.16 | +1.16 |
Taoping | TAOP | Nov 20, 2024 | 0.35 | -2.03 |
Tapestry | TPR | Nov 20, 2024 | 55.30 | -0.58 |
Targa Resources | TRGP | Nov 20, 2024 | 202.84 | -0.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.